Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Di Virgilio

Showing results (1-10 of 219) with videos related to

Pageof 22
Sort By:
Purinergic Signalling|April 12, 2008
Purinergic signalling in the immune system. A brief updateFrancesco Di Virgilio
Frontiers in Oncology|June 16, 2015
A Commentary on "PTX3 is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer"Francesco Di Virgilio
Novartis Foundation Symposium|June 30, 2006
Purinergic signalling between axons and microgliaFrancesco Di Virgilio
British Journal of Pharmacology|October 3, 2003
Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only targetFrancesco Di Virgilio
Current Medicinal Chemistry|December 20, 2014
P2X receptors and inflammationFrancesco Di Virgilio
Purinergic Signalling|April 12, 2008
Purinergic mechanism in the immune system: A signal of danger for dendritic cellsFrancesco Di Virgilio
Molecular & Cellular Oncology|June 17, 2016
P2RX7: A receptor with a split personality in inflammation and cancerFrancesco Di Virgilio
Cancer Research|October 24, 2012
Purines, purinergic receptors, and cancerFrancesco Di Virgilio
Pharmacological Reviews|April 18, 2013
The therapeutic potential of modifying inflammasomes and NOD-like receptorsFrancesco Di Virgilio
Trends in Pharmacological Sciences|August 19, 2007
Liaisons dangereuses: P2X(7) and the inflammasomeFrancesco Di Virgilio
Pageof 22

Showing results (1-10 of 219) with videos related to

Sort By:
Pageof 22
Purinergic Signalling|April 12, 2008
Purinergic signalling in the immune system. A brief updateFrancesco Di Virgilio
Frontiers in Oncology|June 16, 2015
A Commentary on "PTX3 is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer"Francesco Di Virgilio
Novartis Foundation Symposium|June 30, 2006
Purinergic signalling between axons and microgliaFrancesco Di Virgilio
British Journal of Pharmacology|October 3, 2003
Novel data point to a broader mechanism of action of oxidized ATP: the P2X7 receptor is not the only targetFrancesco Di Virgilio
Current Medicinal Chemistry|December 20, 2014
P2X receptors and inflammationFrancesco Di Virgilio
Purinergic Signalling|April 12, 2008
Purinergic mechanism in the immune system: A signal of danger for dendritic cellsFrancesco Di Virgilio
Molecular & Cellular Oncology|June 17, 2016
P2RX7: A receptor with a split personality in inflammation and cancerFrancesco Di Virgilio
Cancer Research|October 24, 2012
Purines, purinergic receptors, and cancerFrancesco Di Virgilio
Pharmacological Reviews|April 18, 2013
The therapeutic potential of modifying inflammasomes and NOD-like receptorsFrancesco Di Virgilio
Trends in Pharmacological Sciences|August 19, 2007
Liaisons dangereuses: P2X(7) and the inflammasomeFrancesco Di Virgilio
Pageof 22